These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 26187496

  • 1. Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation.
    Crawford MJ, Sanatinia R, Barrett B, Byford S, Cunningham G, Gakhal K, Lawrence-Smith G, Leeson V, Lemonsky F, Lykomitrou G, Montgomery A, Morriss R, Paton C, Tan W, Tyrer P, Reilly JG.
    Trials; 2015 Jul 18; 16():308. PubMed ID: 26187496
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled Trial.
    Crawford MJ, Sanatinia R, Barrett B, Cunningham G, Dale O, Ganguli P, Lawrence-Smith G, Leeson V, Lemonsky F, Lykomitrou G, Montgomery AA, Morriss R, Munjiza J, Paton C, Skorodzien I, Singh V, Tan W, Tyrer P, Reilly JG, LABILE study team.
    Am J Psychiatry; 2018 Aug 01; 175(8):756-764. PubMed ID: 29621901
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effectiveness of joint crisis plans for people with borderline personality disorder: protocol for an exploratory randomised controlled trial.
    Moran P, Borschmann R, Flach C, Barrett B, Byford S, Hogg J, Leese M, Sutherby K, Henderson C, Rose D, Slade M, Szmukler G, Thornicroft G.
    Trials; 2010 Feb 23; 11():18. PubMed ID: 20178572
    [Abstract] [Full Text] [Related]

  • 6. Psychological Support for Personality (PSP) versus treatment as usual: study protocol for a feasibility randomized controlled trial of a low intensity intervention for people with personality disorder.
    Crawford MJ, Thana L, Parker J, Turner O, Xing KP, McMurran M, Moran P, Weaver T, Barrett B, Claringbold A, Bassett P, Sanatinia R.
    Trials; 2018 Oct 10; 19(1):547. PubMed ID: 30305148
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Day hospital Mentalization-based treatment versus intensive outpatient Mentalization-based treatment for patients with severe borderline personality disorder: protocol of a multicentre randomized clinical trial.
    Laurenssen EM, Smits ML, Bales DL, Feenstra DJ, Eeren HV, Noom MJ, Köster MA, Lucas Z, Timman R, Dekker JJ, Luyten P, Busschbach JJ, Verheul R.
    BMC Psychiatry; 2014 Nov 18; 14():301. PubMed ID: 25403144
    [Abstract] [Full Text] [Related]

  • 10. PRO*BPD: effectiveness of outpatient treatment programs for borderline personality disorder: a comparison of Schema therapy and dialectical behavior therapy: study protocol for a randomized trial.
    Fassbinder E, Assmann N, Schaich A, Heinecke K, Wagner T, Sipos V, Jauch-Chara K, Hüppe M, Arntz A, Schweiger U.
    BMC Psychiatry; 2018 Oct 19; 18(1):341. PubMed ID: 30340474
    [Abstract] [Full Text] [Related]

  • 11. Day Hospital Mentalization-Based Treatment (MBT-DH) versus treatment as usual in the treatment of severe borderline personality disorder: protocol of a randomized controlled trial.
    Laurenssen EM, Westra D, Kikkert MJ, Noom MJ, Eeren HV, van Broekhuyzen AJ, Peen J, Luyten P, Busschbach JJ, Dekker JJ.
    BMC Psychiatry; 2014 May 22; 14():149. PubMed ID: 24886402
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
    Calvert NW, Burch SP, Fu AZ, Reeves P, Thompson TR.
    J Manag Care Pharm; 2006 May 22; 12(4):322-30. PubMed ID: 16792438
    [Abstract] [Full Text] [Related]

  • 14. Comparing three forms of early intervention for youth with borderline personality disorder (the MOBY study): study protocol for a randomised controlled trial.
    Chanen A, Jackson H, Cotton SM, Gleeson J, Davey CG, Betts J, Reid S, Thompson K, McCutcheon L.
    Trials; 2015 Oct 21; 16():476. PubMed ID: 26489661
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and cost-effectiveness of an experimental short-term inpatient Dialectical Behavior Therapy (DBT) program: study protocol for a randomized controlled trial.
    van den Bosch LM, Sinnaeve R, Hakkaart-van Roijen L, van Furth EF.
    Trials; 2014 May 01; 15():152. PubMed ID: 24885551
    [Abstract] [Full Text] [Related]

  • 16. The addition of STEPPS in the treatment of patients with bipolar disorder and comorbid borderline personality features: a protocol for a randomized controlled trial.
    Riemann G, Weisscher N, Goossens PJ, Draijer N, Apenhorst-Hol M, Kupka RW.
    BMC Psychiatry; 2014 Jun 09; 14():172. PubMed ID: 24912456
    [Abstract] [Full Text] [Related]

  • 17. The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial.
    Crawford MJ, Leeson VC, Evans R, Barrett B, McQuaid A, Cheshire J, Sanatinia R, Lamph G, Sen P, Anagnostakis K, Millard L, Qurashi I, Larkin F, Husain N, Moran P, Barnes TRE, Paton C, Hoare Z, Picchioni M, Gibbon S.
    Ther Adv Psychopharmacol; 2022 Jun 09; 12():20451253221090832. PubMed ID: 35510087
    [Abstract] [Full Text] [Related]

  • 18. INdividual Vocational and Educational Support Trial (INVEST) for young people with borderline personality disorder: study protocol for a randomised controlled trial.
    Chanen AM, Nicol K, Betts JK, Bond GR, Mihalopoulos C, Jackson HJ, Thompson KN, Jovev M, Yuen HP, Chinnery G, Ring J, Allott K, McCutcheon L, Salmon AP, Killackey E.
    Trials; 2020 Jun 26; 21(1):583. PubMed ID: 32591007
    [Abstract] [Full Text] [Related]

  • 19. Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL).
    Simon J, Geddes JR, Gardiner A, Rendell J, Goodwin GM, Mayer S.
    Bipolar Disord; 2018 Dec 26; 20(8):733-745. PubMed ID: 30375699
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol.
    McMain SF, Chapman AL, Kuo JR, Guimond T, Streiner DL, Dixon-Gordon KL, Isaranuwatchai W, Hoch JS.
    BMC Psychiatry; 2018 Jul 17; 18(1):230. PubMed ID: 30016935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.